Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2020 1
2022 3
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Children's Oncology Group's 2023 blueprint for research: Renal tumors.
Geller JI, Hong AL, Vallance KL, Evageliou N, Aldrink JH, Cost NG, Treece AL, Renfro LA, Mullen EA; COG Renal Tumor Committee. Geller JI, et al. Among authors: vallance kl. Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30586. doi: 10.1002/pbc.30586. Epub 2023 Jul 21. Pediatr Blood Cancer. 2023. PMID: 37477907
Intracranial Relapse in Pediatric Sarcoma.
Smith DE, Hamby T, Heym K, Mohamed A, Vallance KL, Ray A. Smith DE, et al. Among authors: vallance kl. J Pediatr Hematol Oncol. 2023 Oct 1;45(7):e810-e816. doi: 10.1097/MPH.0000000000002713. Epub 2023 Jul 14. J Pediatr Hematol Oncol. 2023. PMID: 37526369
Pediatric renal tumor epidemiology: Global perspectives, progress, and challenges.
Libes J, Hol J, Neto JCA, Vallance KL, Tinteren HV, Benedetti DJ, Villar GLR, Duncan C, Ehrlich PF. Libes J, et al. Among authors: vallance kl. Pediatr Blood Cancer. 2023 Jan;70(1):e30006. doi: 10.1002/pbc.30006. Epub 2022 Nov 3. Pediatr Blood Cancer. 2023. PMID: 36326750 Free article. Review.
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.
Mangum R, Reuther J, Sen Baksi K, Gandhi I, Zabriskie RC, Recinos A, Raesz-Martinez R, Lin FY, Potter SL, Sher AC, Kralik SF, Mohila CA, Chintagumpala MM, Muzny D, Hu J, Gibbs RA, Fisher KE, Bernini JC, Gill J, Griffin TC, Tomlinson GE, Vallance KL, Plon SE, Roy A, Parsons DW. Mangum R, et al. Among authors: vallance kl. Pediatr Hematol Oncol. 2023;40(8):719-738. doi: 10.1080/08880018.2023.2228837. Epub 2023 Jun 27. Pediatr Hematol Oncol. 2023. PMID: 37366551
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors.
Coutinho DF, Mundi PS, Marks LJ, Burke C, Ortiz MV, Diolaiti D, Bird L, Vallance KL, Ibáñez G, You D, Long M, Rosales N, Grunn A, Ndengu A, Siddiquee A, Gaviria ES, Rainey AR, Fazlollahi L, Hosoi H, Califano A, Kung AL, Dela Cruz FS. Coutinho DF, et al. Among authors: vallance kl. Med. 2022 Nov 11;3(11):774-791.e7. doi: 10.1016/j.medj.2022.09.002. Epub 2022 Oct 3. Med. 2022. PMID: 36195086 Free PMC article.
BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children's Oncology Group Study AREN03B2.
Goldstein JA, Renfro LA, Jennings LJ, Mullen EA, Geller J, Vallance K, Fernandez CV, Perlman EJ. Goldstein JA, et al. Among authors: vallance k. Arch Pathol Lab Med. 2023 Dec 20. doi: 10.5858/arpa.2022-0528-OA. Online ahead of print. Arch Pathol Lab Med. 2023. PMID: 38116848 Free article.
17 results